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Obstructive sleep apnoea was first brought to prominence by Henri Gastaut, a French epileptologist. Since that time the interface
between epilepsy and sleep disorders has received less attention than might be justified, recognizing that sleep deprivation is a
poignant provocateur for seizures. Sleep deprivation is often used as a diagnostic procedure during electroencephalography (EEG)
when waking EEG has failed to demonstrate abnormality. Patients referred to an outpatient neurological clinic for evaluation of
possible seizures in whom sleep disorder was suspected, either due to snoring during the EEG or based on history, were evaluated
with all-night diagnostic polysomnography (PSG) and appropriate intervention administered as indicated. Patient and seizure
demography, sleep disorder and response to therapy were reviewed and the interface explored. Fifty patients aged between 10
and 83 years underwent PSG. Approximately half were diagnosed with epilepsy and almost three-quarters had sleep disorders
sufficiently intrusive to require therapy (either continuous positive air pressure (CPAP) or medication). With co-existence of
epilepsy and sleep disorders, proper management of sleep disorders provided significant benefit for seizure control. Snoring
during EEG recordings could alert to the possibility of a sleep disorder even with epilepsy diagnosed. Where both epilepsy and
sleep disorder coexist appropriate management of the sleep disorder improves control of the epilepsy.
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The most commonly acknowledged interface between
epilepsy and sleep is the recognition that seizures may
be more common during sleep and within the period im-
mediately following waking1–4. Sleep deprivation has
been used for many years as a powerful provocateur for
diagnostic electroencephalography (EEG) in suspected
cases of epilepsy in which the standard waking EEG
study has failed to demonstrate abnormality5–7.
There is an appreciation that epilepsy may be ex-
acerbated by sleep deprivation4–11. Recently, there
have been reports which indicate that various types
of epilepsy are being misdiagnosed as sleep disor-
ders12–15 reinforcing the need for neurologists to have
a greater understanding of both epilepsy and sleep dis-
orders, so that such misdiagnoses can be avoided in the
future. It is also recognized that sleep disorders may
resemble seizures16 further emphasizing the need to
consider both diagnoses in patients referred for either
diagnosis.
Epilepsy is reported to occur in as many as 2% of
the population when allowance is made for the many
confounding variables17. The widely quoted preva-
lence rate for epilepsy is between 0.5–1%18. Amongst1059–1311/99/020097 + 06 $12.00/0the most common sleep disorders to be encountered,
are sleep apnoea (SA), periodic limb movement in
sleep (PLMS) and upper airway resistance syndrome
(UARS)19. The epidemiology of sleep disorders, and
particularly SA, is far from straightforward20–26 with
patients complaining both of insomnia and hypersom-
nalence as presenting features thereof 26.
The frequency of SA varies between studies with
prevalence figures of 18% to 73% amongst the el-
derly24 being reported as having SA. Two respected
surveys quoted prevalence figures for SA of approxi-
mately 40% for healthy elderly people27, 28. Fleury24
considered 18% to be a more acceptable figure. Parti-
nen and Telakivi22 stated that the highest prevalence
figure for SA in the elderly was approximately 25%
for the over 65-year-olds who had a respiratory distur-
bance index of 5 or more. They also reported a mini-
mum prevalence of SA in adult men of approximately
1%, a figure supported by Phillips et al.23 and Soldators
and Lugaresi25. Hypersomnalence is the more common
presentation of SA19 but is also reported in patients with
epilepsy29, 30. PLMS is also a common sleep disorder
which has been reported to occur in approximately 6%
of a control group of healthy medical centre person-
nel26, 28 with figures as high as 45% for people agedc© 1999 British Epilepsy Association
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Table 1: Patient demographics.
Age at Gender Body mass Referral reason Epilepsy Sleep study Intervention CPAP
sleep study index result required continued
27 Female – ? epilepsy No Hypopnea CPAP Yes
PLMS
27 Male 29.3 2nd opinion Yes Negative – –
27 Male 36.3 2nd opinion Yes UARS CPAP Yes
Sleep apnoea
51 Male 28.7 2nd opinion Yes Sleep apnoea CPAP Yes
10 Male – ? epilepsy Yes PLMS No –
(v. mild)
27 Male 29.7 2nd opinion Yes UARS No –
(v. mild)
66 Male 33.2 2nd opinion Yes Negative – –
72 Female 30 ? epilepsy Yes Sleep apnoea CPAP Yes
PLMS
34 Male – ? epilepsy Yes Hypopnea CBZ –
PLMS
51 Male 35.9 ? epilepsy No Hypopnea CPAP No
27 Male 26.4 ? epilepsy No Negative – –
47 Male 31.6 ? epilepsy No Sleep apnoea CPAP Yes
UARS/PLMS
58 Male 26 ? epilepsy No Sleep apnoea No –
(v. mild)
64 Male 28.4 ? epilepsy No Hypopnea CPAP No
Sleep apnoea
65 Female 37.3 ? epilepsy No Hypopnea CPAP Yes
Sleep apnoea
63 Male – ? epilepsy No Hypopnea No –
(v. mild) phenytoin
Sleep apnoea
(v. mild)
52 Male – ? epilepsy No PLMS Referral –
UARS respiratory
physician
53 Male 36.1 ? epilepsy No Sleep apnoea CPAP Yes
62 Female 30.5 ? epilepsy No Sleep apnoea No –
(v. mild) Weight reduction
42 Male 24.7 2nd opinion Yes Negative – –
51 Male 30.9 ? epilepsy No Sleep apnoea No –
Hypopnea Weight reduction
then ? CPAP
70 Female – 2nd opinion Yes Hypopnea CPAP No
47 Male 26.7 2nd opinion Yes Hypopnea No –
(v. mild)
57 Female 30.4 ? epilepsy No Sleep apnoea CPAP No
UARS
45 Female 30.1 ? epilepsy Yes UARS Referral –
PLMS respiratory
physician
and Sinemet
42 Female 19.4 ? epilepsy No Negative – –
38 Male – 2nd opinion Yes Sleep apnoea CPAP Yes
46 Male 22.5 2nd opinion Yes Negative – –
38 Female 40.6 ? epilepsy No Negative – –
45 Male 30.8 ? epilepsy No UARS CPAP No
Sleep apnoea
48 Male – ? epilepsy No Hypopnea CPAP No
Sleep apnoea
27 Male – 2nd opinion Yes Negative – –
43 Female – ? epilepsy No PLMS Sinemet –
49 Male 29 2nd opinion No UARS/PLMS Sinemet –
43 Male 23.8 ? epilepsy Yes Sleep apnoea CPAP Yes
44 Male 25.1 2nd opinion Yes UARS Sinemet –
PLMS
21 Female 47.9 2nd opinion Yes Hypopnea CPAP No
Weight reduction
58 Male 31.1 ? epilepsy Yes UARS/PLMS Sinemet No
Sleep apnoea CPAP
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Table 1: Continued.
Age at Gender Body mass Referral reason Epilepsy Sleep study Intervention CPAP
sleep study index result required continued
44 Male 30.6 ? epilepsy No UARS Referral respiratory physician –
76 Male 25.9 ? epilepsy No Sleep apnoea CPAP No
41 Female 48.2 ? epilepsy No Sleep apnoea CPAP No
Hypnopnea Weight reduction
20 Female – ? epilepsy No Sleep apnoea PLMS CPAP Yes/No
32 Male – ? epilepsy Yes Sleep apnoea CPAP Yes
83 Male – 2nd opinion Yes Sleep apnoea CPAP No
PLMS Sinemet
39 Female 32.5 2nd opinion Yes Sleep apnoea CPAP No
Hypopnea/PLMS
54 Male 24.4 2nd opinion Yes Sleep apnoea CPAP Yes
67 Male 28.3 ? epilepsy No Sleep apnoea CPAP No
UARS, PLMS
51 Male 32.0 ? epilepsy No Sleep apnoea CPAP No
UARS, PLMS
20 Male 26.0 2nd opinion Yes Worth Considering CPAP No
CPAP
53 Female 16.3 ? epilepsy No UARS CPAP No
PLMS, periodic limb movement in sleep; UARS, upper respiratory airway syndrome; CBZ, carbamazepine.65 years and older having a myoclonus index of 5 or
more27, 31.
In recent times there has been a growing interest in
the relationship between sleep disorders and epilepsy
with an appreciation that the correct management of the
sleep disorders may positively benefit the management
of the epilepsy32–35. These publications each focused
on very small numbers of patients who have epilepsy
(each between four and 10 patients), thereby demon-
strating a potential bias in sample selection and pos-
sible problems for extrapolation to a wider epileptic
community.
The paper that follows reports the findings in a sam-
ple of 50 people referred to a private sleep laboratory
from a centre which specializes in the management of
those with epilepsy.
Materials and Methods
Patients who were referred to a sleep laboratory from a
neurological out-patient clinic which specializes in the
management of people with epilepsy between Septem-
ber 1991 and March 1997 had their records reviewed.
Only those patients who were referred to the clinic for
the evaluation of epilepsy at the time of initial presen-
tation, were included within the study. These patients
were assessed clinically by means of history, examina-
tion and suitable investigation, to determine the valid-
ity of the diagnosis of epilepsy, which was the primary
cause for referral.
Patients who underwent EEG and who demonstrated
early-onset snoring, during either sleep-deprived EEG
or a standard waking study, were referred to the St
Lukes Sleep Centre for all night-diagnostic polysomno-graphic (PSG) study. Other patients referred for assess-
ment of epilepsy but in whom the history was sugges-
tive of SA or in whom other diagnostic procedures,
such as video telemetry, indicated the potential for SA
were also referred for similar PSG investigation.
Parameters measured in PSG studies included: EEG
(using C3-A2 O2-A1 or transverse run from vertex
using 10–20 international placement of electrodes);
EOG (with electrodes at the outer canthus muscle, right
upper and left lower); EMG (from chin and tibialis an-
terior); nasal/oral airflow (employing naso–oral ther-
mocouple); respiratory effort (adopting piezoelectric
technology with abdominal and thoracic belts); oxime-
try; and ECG (by means of modified rhythm strip). The
PSG were recorded using Biologic Sleepscan comput-
erized equipment with each PSG study being manually
scored by a qualified sleep technician.
The data from these studies were reviewed by an in-
dependent researcher experienced in projects dealing
with both epilepsy and sleep disorders. The diagnoses
were determined and compared with the presenting di-
agnosis at the time of referral to the epilepsy clinic.
These data were then compiled and analysed to assess
the interface between the two diagnoses.
Results
Patient demographics
One hundred and twenty-eight files of patients referred
to the sleep laboratory between September 1991 and
March 1997 by the neurology clinic, were reviewed
to ensure that only those who were thought to have
epilepsy at the time of initial assessment at the clinic
were included in the study. This excluded those pa-
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cific sleep analysis. This produced a sample of 50 pa-
tients initially thought to have epilepsy by the refer-
ring doctor. The age range of the 50 patients was 10–
83 years (mean 46  16), comprising 35 males and
15 females (Table 1). Ten of the patients (20%) were
older than 60 years. Body mass index (BMI) was avail-
able for 37 (74%) patients of whom 19 (51%) had
a BMI  30 kg m−2 and only two patients had a
BMI < 20 kg m−2. The range of available BMI was
16.3 to 48.2 kg m−2 (mean 30:2 6:5) (Table 1). Rea-
son for referral for PSG was snoring during the EEG
for 32/50 (64%) with the remainder being selected con-
sequent to a high index of suspicion.
Sleep studies
Forty-two of 50 patients (84%) had some form of sleep
disorder with only 8/50 (16%) demonstrating a com-
pletely negative PSG. Thirty-six of 50 patients (72%)
showed sufficient abnormality to require intervention
(although this included a weight reduction program for
three patients). With BMI  30 kg m−2, 17/19 (89%)
had sleep disturbance sufficient to require intervention
while 10/18 (56%) of those with BMI < 30 kg m−2
required intervention for sleep disorder (Table 1). Of
the 32 who were referred because of snoring during
the EEG, 26/32 (81%) had positive PSG, comprising
17 with SA, seven with hypopnea, 10 with UARS and
eight with PLMS. Twenty-nine of 35 (83%) males and
13/15 (87%) females had positive PSG (Table 1). With
regard to age, 9/10 (90%) of the over 60-years olds had
sleep disorders of whom eight required intervention.
Thirty-three of 40 (83%) of the under 60-years-olds had
positive PSG of whom 27 (68%) required intervention
which was more significant than recommending weight
reduction.
Sleep disorders
Twenty-seven of 50 patients (54%) had SA, 13/50
(26%) had hypopnea and 14/50 (28%) had UARS indi-
cating that a significant number of patients had respi-
ratory causes of disturbed sleep (Table 1). Twenty-six
of 50 patients (52%) had pure respiratory disturbance
without PLMS also contributing some degree of sleep
disturbance as well. Of the 42 patients with some form
of sleep disorder only 17 (40%) had a single pure diag-
nosis with the majority having more than one type of
disturbance. Sixteen of 50 patients (32%) had PLMS
of whom six had sufficient PLMS to justify medica-
tion, predominantly combination of levodopa with car-
bidopa (Sinemet), to be prescribed.
Of the 24/50 patients (48%) who were confirmedto have epilepsy, 19 (79%) also had sleep disorders,
thereby confirming that 23 (55%) of those diagnosed as
having sleep disorders were found not to have epilepsy,
despite it being the cause for referral to the neurology
clinic. Eleven of 28 patients (39%) prescribed CPAP,
were actually using it at the time of the study. Some
said that they would use it; have a CPAP ‘holiday’ and
return to its use. Fifteen of 28 (54%) prescribed CPAP
did not continue its use, either due to emotional fac-
tors (3), mask intolerance (4), lack of efficacy (2), or
lost to follow-up (6).
Outcome measures
Of those in whom intervention was prescribed outcome
measures were determined for 32=36 (89%) of whom
16 (50%) reported improvement (Table 2). It was diffi-
cult to obtain absolute seizure numbers but where avail-
able six (19%) reported being seizure-free or having a
>50% reduction in seizure rate (Table 2).
Discussion
Of those patients referred to a sleep laboratory by a neu-
rological clinic known to have an interest in epilepsy
.n D 128/, 50 patients were initially referred to the neu-
rological clinic with a suspected diagnosis of epilepsy.
Of these 50 patients, 18 were considered definitely to
have epilepsy at the time of referral with 32 probable
epilepsy. After a full evaluation, only 24/50 (48%) re-
tained the diagnosis of epilepsy and of them 19 (79%)
also had sleep disorders, thereby reinforcing the need
for those who manage patients with epilepsy to have
a high index of suspicion for sleep disorders. This is
especially so with the elderly patients, those with a
BMI  30 kg m−2 and those who snore during the
EEG recording.
This sample showed a specificity of 84% (42/50)
with positive yield from referral to a sleep labora-
tory, based upon the selection criteria of snoring during
EEG (32/50, 64%) and upon the seeking of appropri-
ate history while evaluating patients who were initially
thought to have epilepsy.
These findings support earlier studies which report
increased sleep disorders among the elderly and the
obese, irrespective of the concomitant diagnosis of
epilepsy20–25. The reported increase of SA among
males was not found in this sample population although
this may merely reflect the relatively small number of
females in the sample. Of greater importance is the
fact that within this sample, only approximately half
the patients retained the diagnosis of epilepsy after full
evaluation.
CPAP was prescribed for 56% of the population with
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Table 2: Treatment outcome in patients requiring CPAP/Sinemet.
CPAP/Sinemet CPAP Outcome Epilepsy diagnosis
required continued
CPAP No Psychological antipathy to CPAP No
CPAP Yes Sleeping better, more refreshed, decrease in ‘funny turns’ No
CPAP Yes Improvement Yes
CPAP Yes >50% reduction in seizure frequency, feeling better Yes
CPAP Yes Sleeping better, no improvement in seizure control Yes
CPAP No Stopped CPAP as no improvement, though snored less No
CPAP No Mask uncomfortable, patient did not see benefit Yes
Sinemet – Seizure free, improvement with Sinemet Yes
CPAP Yes >50% reduction in seizure frequency Yes
CPAP Not applicable Still waiting for CPAP study, treatment not initiated No
CPAP Yes More alert and talkative, less frequent/severe seizures Yes
CPAP Yes Using CPAP with good effect, patient more alert No
Sinemet – Significant improvement No
CPAP Yes >50% reduction in seizure frequency No
CPAP No Lost to follow-up No
CPAP No Mask intolerance, treatment not initiated No
CPAP Yes Feels better, has more energy, seizure frequency unchanged No
CPAP Yes Not on regular basis, >50% reduction in seizure frequency Yes
Sinemet – Significant improvement No
Sinemet and CPAP Not applicable Sleeping better and longer on Sinemet, CPAP treatment not initiated Yes
Sinemet – Feeling terrific on Sinemet Yes
CPAP No Uncomfortable, unable to tolerate mask No
CPAP Yes/No Machine broke after 1 year, carers saw no benefit No
CPAP No Lost to follow-up No
CPAP Yes Seizure free, more alert and refreshed Yes
Sinemet and CPAP No Patient unable to tolerate mask, improvement on Sinemet Yes
CPAP No Lost to follow-up Yes
CPAP No CPAP on hold (trying weight reduction first) Yes
CPAP No Lost to follow-up No
CPAP No Had CPAP titration, treatment not initiated Yes
CPAP No Lost to follow-up No
CPAP No Lost to follow-up No
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